Advertisement

Topics

Basilea Pharmaceutica AG Company Profile

00:29 EDT 26th September 2018 | BioPortfolio

Basilea Pharmaceutica AG is an independent biopharmaceutical company actively engaged in the discovery and development of innovative drugs for the treatment of bacterial infections, fungal infections and skin diseases associated with high unmet medical needs. Basilea focuses its resources and capabilities on the discovery, development and eventual marketing of innovative medicines. The company is headquartered in Basel, Switzerland.

Location

Grenzacherstrasse 487Postfach

Basel
CH-4005
Switzerland

Contact

Phone: 41 61 6061 111
Fax: 41 61 6061 112
Email: webmaster@basilea.com


News Articles [56 Associated News Articles listed on BioPortfolio]

Basilea Pharmaceutica: Gesamtumsatz um 30% gesteigert - Ausblick für Gesamtumsatz 2018 erhöht

Bad Marienberg (www.anleihencheck.de) - Basilea Pharmaceutica AG (ISIN CH0011432447WKN: A0B9GA) (SIX: BSLN) gab heute die Finanzergebnisse für das erste Halbjahr bis 30. Juni 2018 bekannt, so das U.....

Basilea Pharmaceutica (BSLN) - Oncology product portfolio to drive future growth

Edison Investment Research - Pharmaceutical & healthcare - Basilea Pharmaceutica: Basilea has successfully brought two anti-infective drugs to the market: Cresemba (severe mould infections) and Zevter...

Basilea Pharmaceutica (BSLN) - Cresemba growth, pipeline expansion

Edison Investment Research - Pharmaceutical & healthcare - Basilea Pharmaceutica: Basilea reported a strong set of interim 2018 results; H118 total revenues grew to CHF59.9m (+30%, H117 CHF46.2m). Not...

Basilea Pharmaceutica (BSLN) - Strength in numbers

Edison Investment Research - Pharmaceutical & healthcare - Basilea Pharmaceutica: Basilea reported a definable FY17, as a multitude of licensing/distribution agreements announced in 2016/17 for launch...

Edison Investment Research Limited: Edison issues outlook on Basilea Pharmaceutica (BSLN)

Dow Jones received a payment from EQS/DGAP to publish this press release. Edison Investment Research Limited Edison Investment Research Limited: Edison issues outlook on Basilea Pharmaceutica (BSL...

Basilea doses first patient in Phase lla study of BAL101553

Switzerland-based Basilea Pharmaceutica has dosed the first patient in the Phase lla expansion part of a Phase l/lla clinical trial...Read More... The post Basilea doses first patient in Phase lla stu...

Hikma Pharma launches Basilea's hospital antibiotic Zevtera in Saudi Arabia

Basilea Pharmaceutica Ltd. announced that its partner Hikma Pharmaceuticals LLC has launched Basilea's hospital antibiotic Zevtera (ceftobiprole) in Saudi Arabia.

Basilea gets rights to ArQule's derazantinib

Basilea Pharmaceutica Ltd. licensed exclusive global rights (excluding China, Hong Kong, Macau, and Taiwan) to develop, manufacture, and sell ArQule Ltd.’s fibroblast growth factor receptor antagoni...

PubMed Articles [59 Associated PubMed Articles listed on BioPortfolio]

The Structure and Activity of Double-Nitroimidazoles. A Mini-Review.

Many interesting applications have been found for nitroimidazoles as therapeutic agents. Among others, some of these compounds can radiosensitize hypoxic tumor cells. The introduction of a second nitr...

SYNTHESIS OF NOVEL 1,4,5,6,7,8-HEXAHYDROQUINOLINES OF POTENTIAL ANTIMICROBIAL ACTIVITY.

A number of 2,3-disubstituted-1-cyclohexyl 4-(3,4-dimethoxyphenyl-1,4,5,6,7,8)-hexahydroquinolines and 5-(3,4-dimethoxyphenyl-10-cyclohexyl-3,4,5,6,7,8,9,10-octahydro)-3H-pyrimido[4,5-b]quinolines wer...

Anti-retroviral drugs: current state and development in the next decade.

The pace of discovery of new antiretroviral (ARV) drugs has slowed, although the efficacy and safety of once-daily fixed dose combinations have been extensively investigated. Several traditional ARV d...

SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL SCREENING OF DIANDRINE A.

Synthesis of a proline-rich cyclic hexapeptide - diandrine A [VI] was accomplished by coupling of tetrapeptide unit Boc-Gly-Pro-Trp-Pro-OH with dipeptide unit Tyr-Phe-OMe followed by cyclization of li...

NEW PYRIDINE AND TRIAZOLOPYRIDINE DERIVATIVES: SYNTHESIS, ANTIMICROBIAL AND ANTIOXIDANT EVALUATION.

A novel series of pyridine and triazolopyridine derivatives have been synthesized (1-17) and characterized on the basis of their elemental analyses and spectral data. In vitro antibacterial, antifunga...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

The objective of this study was to investigate the effect of three different types of occlusive overlays on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Myl...

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

The objective of this study was to investigate the effect of clinical procedures on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Mylan Pharmaceuticals Inc. ...

Vaginal Misoprostol Before IUD Insertion in Women With Cesarean Scar

Groups of study: 120 candidates for Cu T 380A IUD insertion were enrolled in the study. They were divided into two groups: Group 1: Sixty women received 600 micrograms of misoprostol vagi...

Companies [7 Associated Companies listed on BioPortfolio]

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG is an independent biopharmaceutical company actively engaged in the discovery and development of innovative drugs for the treatment of bacterial infections, fungal infections ...

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem...

Janssen Pharmaceutica N.V.

Aurora Biomolecules

Aurora Biomolecules is situated in the heart of Cambridge & specialises in polyclonal antibody production and peptide synthesis for academia, pharmaceutica and industry.anti-GFP antibodiesContract man...

Janssen Pharmaceutica N.V

We are part of the world’s largest healthcare company, Johnson & Johnson, and enjoy an international reputation for pharmaceutical innovation and quality. For instance, EPREX™ , a breakthrough in ...

More Information about "Basilea Pharmaceutica AG" on BioPortfolio

We have published hundreds of Basilea Pharmaceutica AG news stories on BioPortfolio along with dozens of Basilea Pharmaceutica AG Clinical Trials and PubMed Articles about Basilea Pharmaceutica AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Basilea Pharmaceutica AG Companies in our database. You can also find out about relevant Basilea Pharmaceutica AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...


Corporate Database Quicklinks



Searches Linking to this Company Record